Randy L. Smith - Publications

Affiliations: 
1990-1991 Psychiatry University of Pennsylvania, Philadelphia, PA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Benneyworth MA, Smith RL, Sanders-Bush E. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2206-16. PMID 17957214 DOI: 10.1038/sj.npp.1301600  0.416
2007 Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, Sanders-Bush E. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Molecular Pharmacology. 72: 477-84. PMID 17526600 DOI: 10.1124/Mol.107.035170  0.32
2007 Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. The Journal of Pharmacology and Experimental Therapeutics. 320: 662-9. PMID 17077317 DOI: 10.1124/jpet.106.112946  0.44
2005 Barrett RJ, Caul WF, Smith R. Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task. Pharmacology, Biochemistry, and Behavior. 81: 1-8. PMID 15894057 DOI: 10.1016/j.pbb.2004.12.012  0.391
2005 Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1693-702. PMID 15756304 DOI: 10.1038/sj.npp.1300711  0.359
2005 Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology. 179: 854-62. PMID 15645221 DOI: 10.1007/s00213-004-2108-z  0.398
2003 Smith RL, Barrett RJ, Sanders-Bush E. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice. Psychopharmacology. 166: 61-8. PMID 12474110 DOI: 10.1007/s00213-002-1252-6  0.434
2002 Smith RL, Gresch PJ, Barrett RJ, Sanders-Bush E. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release. Pharmacology, Biochemistry, and Behavior. 72: 77-85. PMID 11900772 DOI: 10.1016/S0091-3057(01)00723-7  0.429
1999 Smith RL, Barrett RJ, Sanders-Bush E. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology. 144: 248-54. PMID 10435391 DOI: 10.1007/s002130051000  0.424
1998 Smith RL, Canton H, Barrett RJ, Sanders-Bush E. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacology, Biochemistry, and Behavior. 61: 323-30. PMID 9768567 DOI: 10.1016/S0091-3057(98)00110-5  0.375
1995 Barrett RJ, Caul WF, Huffman EM, Smith RL. Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement. Psychopharmacology. 113: 289-96; discussion 2. PMID 7862836 DOI: 10.1007/BF02245196  0.3
1989 Barrett RJ, Smith RL. Time dependent pentylenetetrazol-like cues subsequent to diazepam administration. Psychopharmacology. 96: 169-73. PMID 3148142 DOI: 10.1007/BF00177556  0.363
Show low-probability matches.